Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast

NCT00857714 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Terminated due to low accrual

Conditions

Ductal Carcinoma in Situ

Interventions

DRUG: lapatinib

Sponsor

Indiana University

Collaborators

[object Object]